MENU
IPHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Innate Pharma SA (IPHA) Earnings Date & Reports
Innate Pharma SA is a clinical-stage biotechnology company... Show more
A.I. Advisor
published Earnings
IPHA is expected to report earnings to rise 56.57% to -23 cents per share on September 17
Q2'26
Est.
$-0.24
Q1'26
Beat
by $0.01
Q4'25
Missed
by $0.22
Q4'24
Beat
by $0.10
Q2'23
Beat
by $0.16
The last earnings report on May 13 showed earnings per share of -15 cents, beating the estimate of -16 cents. With 100.00 shares outstanding, the current market capitalization sits at 173.21M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment
Industry Biotechnology
Profile
Details
Industry
N/A
Address
117, Avenue de Luminy
Phone
+33 430303030
Employees
164
Web
https://www.innate-pharma.com